<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16228</article-id><article-id pub-id-type="doi">10.7554/eLife.16228</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-54326"><name><surname>Moutel</surname><given-names>Sandrine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-54327"><name><surname>Bery</surname><given-names>Nicolas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54328"><name><surname>Bernard</surname><given-names>Virginie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54329"><name><surname>Keller</surname><given-names>Laura</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1786-9760</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-61963"><name><surname>Lemesre</surname><given-names>Emilie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54330"><name><surname>de Marco</surname><given-names>Ario</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54331"><name><surname>Ligat</surname><given-names>Laetitia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54332"><name><surname>Rain</surname><given-names>Jean-Christophe</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-54333"><name><surname>Favre</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-54334"><name><surname>Olichon</surname><given-names>Aurélien</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-9885"><name><surname>Perez</surname><given-names>Franck</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9129-9401</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution>Inserm, UMR 1037-CRCT</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">plateau de protéomique</institution>, <institution>CRCT</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution>Hybrigenics Service SA</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-8518"><name><surname>Akhmanova</surname><given-names>Anna</given-names></name><role>Reviewing editor</role><aff><institution>Utrecht University</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>aurelien.olichon@inserm.fr</email> (AO);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Franck.Perez@curie.fr</email> (FP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>07</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e16228</elocation-id><supplementary-material><ext-link xlink:href="elife-16228-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>20</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>18</day><month>07</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Moutel et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Moutel et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p><italic>In vitro</italic> selection of antibodies allows to obtain highly functional binders, rapidly and at lower cost. Here, we describe the first fully synthetic phage display library of humanized llama single domain antibody (NaLi-H1: Nanobody Library Humanized 1). Based on a humanized synthetic single domain antibody (hs2dAb) scaffold optimized for intracellular stability, the highly diverse library provides high affinity binders without animal immunization. NaLi-H1 was screened following several selection schemes against various targets (Fluorescent proteins, actin, tubulin, p53, HP1). Conformation antibodies against active RHO GTPase were also obtained. Selected hs2dAb were used in various immunoassays and were often found to be functional intrabodies, enabling tracking or inhibition of endogenous targets. Functionalization of intrabodies allowed specific protein knockdown in living cells. Finally, direct selection against the surface of tumor cells produced hs2dAb directed against tumor-specific antigens further highlighting the potential use of this library for therapeutic applications.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>E. coli</kwd><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Institut Curie</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Moutel</surname><given-names>Sandrine</given-names></name><name><surname>Bernard</surname><given-names>Virginie</given-names></name><name><surname>de Marco</surname><given-names>Ario</given-names></name><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004794</institution-id><institution>Centre National de la Recherche Scientifique</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Moutel</surname><given-names>Sandrine</given-names></name><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001677</institution-id><institution>Institut National de la Santé et de la Recherche Médicale</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bery</surname><given-names>Nicolas</given-names></name><name><surname>Keller</surname><given-names>Laura</given-names></name><name><surname>Ligat</surname><given-names>Laetitia</given-names></name><name><surname>Favre</surname><given-names>Gilles</given-names></name><name><surname>Olichon</surname><given-names>Aurélien</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-09-BIOT-05</award-id><principal-award-recipient><name><surname>Moutel</surname><given-names>Sandrine</given-names></name><name><surname>Rain</surname><given-names>Jean-Christophe</given-names></name><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001677</institution-id><institution>Institut National de la Santé et de la Recherche Médicale</institution></institution-wrap></funding-source><award-id>ITS-201103</award-id><principal-award-recipient><name><surname>de Marco</surname><given-names>Ario</given-names></name><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>DEQ20120323723</award-id><principal-award-recipient><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Groupe de Recherche of the Claudius Regaud Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Favre</surname><given-names>Gilles</given-names></name><name><surname>Olichon</surname><given-names>Aurélien</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>LABEX CellTisPhyBio</institution></institution-wrap></funding-source><award-id>11-LBX-0038</award-id><principal-award-recipient><name><surname>Moutel</surname><given-names>Sandrine</given-names></name><name><surname>Bernard</surname><given-names>Virginie</given-names></name><name><surname>de Marco</surname><given-names>Ario</given-names></name><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>IDEX Paris Sciences Lettres</institution></institution-wrap></funding-source><award-id>ANR-10-IDEX-0001-02 PSL</award-id><principal-award-recipient><name><surname>Moutel</surname><given-names>Sandrine</given-names></name><name><surname>Bernard</surname><given-names>Virginie</given-names></name><name><surname>de Marco</surname><given-names>Ario</given-names></name><name><surname>Perez</surname><given-names>Franck</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Sandrine Moutel, Co-inventor on a patent application (filled under ref: WO/2015/063331) that covers the hs2dAb scaffold and the commercial use of the library. The library has been licensed to Hybrigenics Service SA, which will perform screens on a fee-for-service basis.A consultant for Hybrigenics Service SA.</p></fn><fn fn-type="conflict" id="conf3"><p>Jean-Christophe Rain, Employed by, and a stockholder in, Hybrigenics Service SA.</p></fn><fn fn-type="conflict" id="conf4"><p>Aurélien Olichon, Co-inventor on a patent application (filled under ref: WO/2015/063331) that covers the hs2dAb scaffold and the commercial use of the library. The library has been licensed to Hybrigenics Service SA, which will perform screens on a fee-for-service basis.</p></fn><fn fn-type="conflict" id="conf5"><p>Franck Perez, Co-inventor on a patent application (filled under ref: WO/2015/063331) that covers the hs2dAb scaffold and the commercial use of the library. The library has been licensed to Hybrigenics Service SA, which will perform screens on a fee-for-service basis.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec></back></article>